| Molecular classification of cancer: class discovery and class prediction by gene expression monitoring TR Golub, DK Slonim, P Tamayo, C Huard, M Gaasenbeek, JP Mesirov, ... science 286 (5439), 531-537, 1999 | 15526 | 1999 |
| The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia DA Arber, A Orazi, R Hasserjian, J Thiele, MJ Borowitz, MM Le Beau, ... Blood, The Journal of the American Society of Hematology 127 (20), 2391-2405, 2016 | 10636 | 2016 |
| The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes JW Vardiman, J Thiele, DA Arber, RD Brunning, MJ Borowitz, A Porwit, ... Blood, The Journal of the American Society of Hematology 114 (5), 937-951, 2009 | 6098 | 2009 |
| Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel H Döhner, E Estey, D Grimwade, S Amadori, FR Appelbaum, T Büchner, ... Blood, The Journal of the American Society of Hematology 129 (4), 424-447, 2017 | 5704 | 2017 |
| The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting, Airlie House … NL Harris, ES Jaffe, J Diebold, G Flandrin, HK Muller-Hermelink, ... Annals of Oncology 10 (12), 1419-1432, 1999 | 4539 | 1999 |
| Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet H Döhner, EH Estey, S Amadori, FR Appelbaum, T Büchner, AK Burnett, ... Blood, The Journal of the American Society of Hematology 115 (3), 453-474, 2010 | 4272 | 2010 |
| Acute myeloid leukemia H Döhner, DJ Weisdorf, CD Bloomfield New England Journal of Medicine 373 (12), 1136-1152, 2015 | 3457 | 2015 |
| Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic … BD Cheson, JM Bennett, KJ Kopecky, T Büchner, CL Willman, EH Estey, ... Journal of clinical oncology 21 (24), 4642-4649, 2003 | 3016 | 2003 |
| Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation RM Stone, SJ Mandrekar, BL Sanford, K Laumann, S Geyer, ... New England Journal of Medicine 377 (5), 454-464, 2017 | 2121 | 2017 |
| Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid … JC Byrd, K Mrózek, RK Dodge, AJ Carroll, CG Edwards, DC Arthur, ... Blood, The Journal of the American Society of Hematology 100 (13), 4325-4336, 2002 | 2088 | 2002 |
| Aberrant CpG-island methylation has non-random and tumour-type–specific patterns JF Costello, MC Frühwald, DJ Smiraglia, LJ Rush, GP Robertson, X Gao, ... Nature genetics 24 (2), 132-138, 2000 | 1768 | 2000 |
| Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia KG Roberts, Y Li, D Payne-Turner, RC Harvey, YL Yang, D Pei, ... New England journal of medicine 371 (11), 1005-1015, 2014 | 1470 | 2014 |
| All-trans-Retinoic Acid in Acute Promyelocytic Leukemia MS Tallman, JW Andersen, CA Schiffer, FR Appelbaum, JH Feusner, ... New England Journal of Medicine 337 (15), 1021-1028, 1997 | 1274 | 1997 |
| Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis … A Tefferi, J Thiele, A Orazi, HM Kvasnicka, T Barbui, CA Hanson, G Barosi, ... Blood, The Journal of the American Society of Hematology 110 (4), 1092-1097, 2007 | 1179 | 2007 |
| Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. BD Cheson, PA Cassileth, DR Head, CA Schiffer, JM Bennett, ... Journal of Clinical Oncology 8 (5), 813-819, 1990 | 1000 | 1990 |
| Cytogenetics in acute leukemia K Mrozek, NA Heerema, CD Bloomfield Blood reviews 18 (2), 115-136, 2004 | 969 | 2004 |
| IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study G Marcucci, K Maharry, YZ Wu, MD Radmacher, K Mrózek, D Margeson, ... Journal of clinical oncology 28 (14), 2348, 2010 | 951 | 2010 |
| MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly … R Garzon, S Liu, M Fabbri, Z Liu, CEA Heaphy, E Callegari, S Schwind, ... Blood, The Journal of the American Society of Hematology 113 (25), 6411-6418, 2009 | 912 | 2009 |
| Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype CD Bloomfield, D Lawrence, JC Byrd, A Carroll, MJ Pettenati, ... Cancer research 58 (18), 4173-4179, 1998 | 904 | 1998 |
| Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study P Paschka, G Marcucci, AS Ruppert, K Mrózek, H Chen, RA Kittles, ... Journal of Clinical Oncology 24 (24), 3904-3911, 2006 | 855 | 2006 |
